Differences in stem cell processing lead to distinct secretomes secretion – implications for differential results of previous clinical trials of stem cell therapy for myocardial infarction.

Wernly, B, Gonçalves, I, Kiss, A, Paar, V, Mösenlechner, T, Leisch, M, Santer, D, Motloch, L, Klein, KU, Tretter, EV, Kretzschmar, D, Podesser, B, Jung, C, Hoppe, UC, Lichtenauer, M.

http://www.ncbi.nlm.nih.gov/pubmed/28731525